Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer

Gene Expression

Volumn 16, Issue 3, 2015, Pages 101-108

  Walesky, Chad ^a,b   Apte, Udayan ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

C Myc; Diethylnitrosamine; Hepatocellular carcinoma (HCC); Hepatocytes; Proliferating cell nuclear antigen (PCNA)

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIN D1; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MICRORNA; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR; CYCLINE; DIETHYLNITROSAMINE; HEPATOCYTE NUCLEAR FACTOR 4; MYC PROTEIN; MYC PROTEIN, HUMAN;

BILE DUCT CARCINOMA; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; DNA BINDING; ENZYME INHIBITION; ENZYME MECHANISM; EPIGENETIC REPRESSION; FEEDBACK SYSTEM; GENE EXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; KIDNEY CARCINOMA; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER DEVELOPMENT; LIVER FUNCTION; LIVER PARENCHYMA; NONHUMAN; ONCOGENE C MYC; POINT MUTATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; RNA SEQUENCE; TRANSCRIPTION INITIATION; ANIMAL; GENETICS; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIETHYLNITROSAMINE; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; HUMANS; MICE; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84928390612     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/105221615X14181438356292     Document Type: Review

References (66)

1. Sladek FM, Zhong WM, Lai E, Darnell JE liver-enriched transcription factor HNF-4 is a novel member of the steroid-hormone receptor superfamily. Genes Dev 1990; 4: 2353-2365.
2. Drewes T, Senkel S, Holewa B, Ryffel GU. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol 1996; 16:925-931.
3. Jiang S, Tanaka T, Iwanari H, Hotta H, Yamashita H, Kumakura J, Watanabe Y, et al. Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4αlpha) isoforms in human and rats. Nucl Recept 2003; 1:5.
4. Duncan SA, Manova K, Chen WS, Hoodless P, Weinstein DC, Bachvarova RF, Darnell JE, Jr. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc Natl Acad Sci USA 1994; 91:7598-7602.
5. Chen WS, Manova K, Weinstein DC, Duncan SA, Plump AS, Prezioso VR, Bachvarova RF, et al. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev 1994; 8:2466-2477.
6. Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: Functional and pathological consequences. J Mol Endocrinol 2001; 27:11-29.
7. Torres-Padilla ME, Fougere-Deschatrette C, Weiss MC. Expression of HNF4αlpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing. Mech Dev 2001; 109:183-193.
8. Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F. Multidomain integration in the structure of the HNF-4alpha nuclear receptor complex. Nature 2013; 495:394-398.
9. Yuan X, Ta TC, Lin M, Evans JR, Dong Y, Bolotin E, Sherman MA, et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PloS One 2009; 4:e5609.
10. Wang JC, Stafford JM, Granner DK SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J Biol Chem 1998; 273:30847-30850.
11. Dell H, Hadzopoulou-Cladaras M. CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J Biol Chem 1999; 274:9013-9021.
12. Sladek FM, Ruse MD, Jr., Nepomuceno L, Huang SM, Stallcup MR. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. Mol Cell Biol 1999; 19:6509-6522.
13. Soutoglou E, Katrakili N, Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell 2000; 5:745-751.
14. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413:131-138.
15. Iordanidou P, Aggelidou E, Demetriades C, Hadzopoulou-Cladaras M. Distinct amino acid residues may be involved in coactivator and ligand interactions in hepatocyte nuclear factor-4alpha. J Biol Chem 2005; 280:21810-21819.
16. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001; 21:1393-1403.
17. Inoue Y, Yu AM, Inoue J, Gonzalez FJ. Hepatocyte nuclear factor 4 alpha is a central regulator of bile acid conjugation. J Biol Chem 2004; 279:2480-2489.
18. Inoue Y, Peters LL, Yim SH, Inoue J, Gonzalez FJ. Role of hepatocyte nuclear factor 4 alpha in control of blood coagulation factor gene expression. J Mol Med 2006; 84:334-344.
19. Inoue Y, Yu AM, Yim SH, Ma X, Krausz KW, Inoue J, Xiang CC, et al. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha. J lipid Res 2006; 47:215-227.
20. Gonzalez FJ. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet 2008; 23:2-7.
21. Sel S, Ebert T, Ryffel GU, Drewes T. Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha. Cancer lett 1996; 101:205-210.
22. Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF. Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 2003; 3:31.
23. Lucas B, Grigo K, Erdmann S, Lausen J, Klein-Hitpass L, Ryffel GU. HNF4αlpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 2005; 24:6418-6431.
24. Grigo K, Wirsing A, Lucas B, Klein-Hitpass L, Ryffel GU. HNF4 alpha orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells. Biol Chem 2008; 389: 179-187.
25. Chiba H, Itoh T, Satohisa S, Sakai N, Noguchi H, Osanai M, Kojima T, et al. Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overex-pression of hepatocyte nuclear factor-4alpha. Exp Cell Res 2005; 302:11-21.
26. Erdmann S, Senkel S, Arndt T, Lucas B, Lausen J, Klein-Hitpass L, Ryffel GU, et al. Tissue-specific transcription factor HNF4αlpha inhibits cell proliferation and induces apoptosis in the pancreatic INS-1 beta-cell line. Biol Chem 2007; 388:91-106.
27. Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K, Daigo K, et al. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol 2006; 208: 662-672.
28. Chellappa K, Jankova L, Schnabl JM, Pan S, Brelivet Y, Fung Cl, Chan C, et al. Src tyrosine kinase phosphorylation of nuclear receptor HNF4αlpha correlates with iso-form-specific loss of HNF4αlpha in human colon cancer. Proc Natl Acad Sci USA 2012; 109:2302-2307.
29. Duncan SA, Nagy A, Chan W. Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: Tetraploid rescue of Hnf-4(-/-) embryos. Development 1997; 124:279-287.
30. Li J, Ning G, Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 2000; 14:464-474.
31. Mizuguchi T, Mitaka T, Hirata K, Oda H, Mochizuki Y. Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes. J Cell Physiol 1998; 174:273-284.
32. Spath GF, Weiss MC. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol 1998; 140:935-946.
33. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI, et al. Progression of HCC in mice is associated with a down-regulation in the expression of hepatocyte nuclear factors. Hepatology 2004; 39:1038-1047.
34. Holland JF, Cancer medicine. In. 5th ed. Hamilton, Ontario; New York: B.C. Decker, 2000; 2546 p.
35. lazarevich NL, Shavochkina DA, Fleishman DI, Kustova IF, Morozova O V, Chuchuev ES, Patyutko YI. Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumors progression. Exp Oncol 2010; 32:167-171.
36. Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, Hou JL, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 2008; 48: 1528-1539.
37. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 2010; 70:7640-7651.
38. Walesky C, Edwards G, Borude P, Gunewardena S, O'Neil M, Yoo B, Apte U. Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. Hepatology 2013; 57:2480-2490.
39. Walesky C, Gunewardena S, Terwilliger EF, Edwards G, Borude P, Apte U. Hepatocyte-specific deletion of hepatocyte nuclear factor-4alpha in adult mice results in increased hepatocyte proliferation. A J Physiol Gastrointest liver Physiol 2013; 304:G26-37.
40. Bonzo JA, Ferry CH, Matsubara T, Kim JH, Gonzalez FJ. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4alpha in adult mice. J Biol Chem 2012; 287:7345-7356.
41. Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, et al. Mutant IDH inhibits HNF-4alpha to block hepatocyte differentiation and promote biliary cancer. Nature 2014; 513:110-114.
42. Wang P, Dong Q, Zhang C, Kuan PF, Liu Y, Jeck WR, Andersen JB, et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 2013; 32:3091-3100.
43. Borger DR, Tanabe KK, Fan KC, Lopez HU, Fantin VR, Straley KS, Schenkein DP, et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 2012; 17:72-79.
44. Razumilava N, Gores GJ Cholangiocarcinoma. lancet 2014; 383:2168-2179.
45. Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, et al. Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. Hum Pathol 2013; 44:1216-1222.
46. Lazarevich NL, Shavochkina DA, Fleishman DI, Kustova IF, Morozova OV, Chuchuev ES, Patyutko YI. Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression. Exp Oncol 2010; 32:167-171.
47. Ruse MD, Jr., Privalsky ML, Sladek FM. Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: Modulation by the F domain. Mol Cell Biol 2002; 22:1626-1638.
48. Ungaro P, Teperino R, Mirra P, Longo M, Ciccarelli M, Raciti GA, Nigro C, et al. Hepatocyte nuclear factor (HNF)-4alpha-driven epigenetic silencing of the human PED gene. Diabetologia 2010; 53:1482-1492.
49. Amati B, Alevizopoulos K, Vlach J. Myc and the cell cycle. Front Biosci 1998; 3:d250-268.
50. Eilers M, Schirm S, Bishop JM. The MyC protein activates transcription of the alpha-prothymosin gene. EMBO J 1991; 10:133-141.
51. Penn LJ, Laufer EM, Land H. C-MyC: Evidence for multiple regulatory functions. Semin Cancer Biol 1990; 1:69-80.
52. Sladek FM. The yin and yang of proliferation and differentiation: Cyclin D1 inhibits differentiation factors ChREBP and HNF4alpha. Cell Cycle 2012; 11:3156-3157.
53. Hanse EA, Mashek DG, Becker JR, Solmonson AD, Mullany lK, Mashek MT, Towle HC, et al. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4alpha. Cell Cycle 2012; 11:2681-2690.
54. D'Angiolella V, Donato V, Forrester FM, Jeong yT, Pellacani C, Kudo Y, Saraf A, et al. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell 2012; 149:1023-1034.
55. D'Angiolella V, Esencay M, Pagano M. A cyclin without cyclin-dependent kinases: Cyclin F controls genome stability through ubiquitin-mediated proteolysis. Trends Cell Biol 2013; 23:135-140.
56. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, et al. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011; 147:1233-1247.
57. Yin C, Wang PQ, Xu WP, Yang Y, Zhang Q, Ning BF, Zhang PP, et al. Hepatocyte nuclear factor-4alpha reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DlK1-DIO3 region. Hepatology 2013.
58. Sims RJ, 3rd, Reinberg D. Is there a code embedded in proteins that is based on post-translational modifications? Nat Rev Mol Cell Biol 2008; 9:815-820.
59. Witze ES, Old WM, Resing KA, Ahn NG. Mapping protein post-translational modifications with mass spectrometry. Nature Methods 2007; 4:798-806.
60. Yokoyama A, Katsura S, Ito R, Hashiba W, Sekine H, Fujiki R, Kato S. Multiple post-translational modifications in hepatocyte nuclear factor 4alpha. Biochem Biophys Res Commun 2011; 410:749-753.
61. Viollet B, Kahn A, Raymondjean M. Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol Cell Biol 1997; 17: 4208-4219.
62. Ktistaki E, Ktistakis NT, Papadogeorgaki E, Talianidis I. Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci USA 1995; 92:9876-9880.
63. Li X, Salisbury-Rowswell J, Murdock AD, Forse RA, Burke PA. Hepatocyte nuclear factor 4 response to injury involves a rapid decrease in DNA binding and transactivation via a JAK2 signal transduction pathway. Biochem J 2002; 368:203-211.
64. Lu JW, Hsia Y, Yang Wy, Lin YI, LI CC, Tsai TF, Chang KW, et al. Identification of the common regulators for hepato-cellular carcinoma induced by hepatitis B virus X antigen in a mouse model. Carcinogenesis 2012; 33:209-219.
65. Yue Hy, Yin C, Hou JL, Zeng X, Chen YX, Zhong W, Hu PF, et al. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats. Gut 2010; 59:236-246.
66. Fan TT, Hu PF, Wang J, Wei J, Zhang Q, Ning BF, Yin C, et al. Regression effect of hepatocyte nuclear factor 4alpha on liver cirrhosis in rats. J Dig Dis 2013; 14:318-327.